References
Thakral C, Thomas L, Gajra A, Hutchison RE, Ravizzini GC, Vajpayee N (2009) Plasmablastic lymphoma in an immunocompetent patient. J Clin Oncol 27(25):e78–81. doi:10.1200/JCO.2009.22.2208
Montes-Moreno S, Montalban C, Piris MA (2012) Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma 53(2):185–194. doi:10.3109/10428194.2011.608447
Masgala A, Christopoulos C, Giannakou N, Boukis H, Papadaki T, Anevlavis E (2007) Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol 86(8):615–618. doi:10.1007/s00277-007-0280-z
Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C (2004) Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 128(5):581–584. doi:10.1043/1543-2165(2004)128<581:PLOTCL>2.0.CO;2
Horna P, Hamill JR Jr, Sokol L, Glass LF (2013) Primary cutaneous plasmablastic lymphoma in an immunocompetent patient. J Am Acad Dermatol 69(5):e274–276. doi:10.1016/j.jaad.2013.06.050
Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, Portlock C, Noy A (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679. doi:10.1093/annonc/mdh399
Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736–747
Yan M, Dong Z, Zhao F, Chauncey T, Deauna-Limayo D, Wang-Rodriguez J, Liu D, Wang HY, Pilz R (2014) CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab. Eur J Haematol. doi:10.1111/ejh.12286
Blade J, Fernandez de Larrea C, Rosinol L, Cibeira MT, Jimenez R, Powles R (2011) Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 29(28):3805–3812. doi:10.1200/JCO.2011.34.9290
Sekiguchi Y, Asahina T, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M (2013) A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature. J Clin Exp Hematop: JCEH 53(1):21–28
Funding source
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1
CT-PET scan of a representative PET-positive lesion in the cervical spine that is not osteolytic as shown by the CT component of the scan. (JPEG 68 kb)
Rights and permissions
About this article
Cite this article
Johnston, A.C., Naresh, K., Barwick, T. et al. Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma. Ann Hematol 94, 691–692 (2015). https://doi.org/10.1007/s00277-014-2226-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2226-6